December 22, 2016
Note: MobiHealthNews will be taking tomorrow off for the holidays. We'll be back on Monday with a week of special issues looking back at 2016 and ahead at 2017, and back to our normal coverage on January 2nd. We wish you and yours a happy holiday season.
While the shift to value-based care has driven digital health innovation overall, the tech-enabled advances haven’t necessarily touched every...
October 14, 2016
Ovuline, which makes a suite of women's and family health apps, has raised $10 million in new funding and is renaming the company "Ovia Health". Ovia was already the brand name attached to its suite of apps. Martin Ventures and Zaffre Investments, the investment arm of Blue Cross Blue Shield of Massachusetts, led the round. All of the company's previous investors returned for the round, including...
May 26, 2015
Boston-based women's health app developer Ovuline has raised $3.2 million from Martin Ventures and Zaffre Investments, the investment arm of Blue Cross Blue Shield of Massachusetts. About $1 million of this investment came from Zaffre Investments. This brings the company’s total funding to at least $5.7 million.
Ovuline offers two apps, Ovia Pregnancy and Ovia Fertility, which ...
May 18, 2015
Of the nearly 100 iOS apps focused on tracking women's reproductive health, few have been assessed or recommended by reproductive health experts, a recent study of such apps and the corresponding literature has concluded.
The study was published in Obstetrics & Gynecology and it included an analysis of 94 unique menstrual cycle tracking apps found in Apple App Store, as well...
April 28, 2015
Boston-based Ovuline, which offers two women's health apps, has released a number of statistics about the 1 million women that use their Ovia Pregancy app.
The app helps women who have conceived to track their pregnancy with a baby calendar, health alerts, and curated pregnancy articles.
The average age of women using the app is 26.8 years old. These women have reported feeling happy twice as...
March 3, 2014
Last year, MobiHealthNews pointed out that although digital health fertility services have been around since at least 2009, digital health fertility tools were showing signs of early market traction by focusing on conception. The companies we discussed at the time were Kindara, Ovuline, and DuoFertility, which all aimed to help women with conception.
Since then, other companies that focused on...
January 29, 2014
A little over 5 percent of women seek information about reproductive health from smartphone apps, while around 32 percent get information from medical websites, according to Yale University School of Medicine's online anonymized survey of 1,000 women ages 18 to 40, conducted in March 2013.
Manufacturers of First Response pregnancy test Church and Dwight funded the study.
The study, published in...
October 23, 2013
Fertility tracker Ovuline raised $1.1 million from repeat investors Lightbank Ventures, LionBird Ltd, Bullet Time Venture, CEO Paris Wallace told MobiHealthNews. This brings the company's total announced funding to $2.5 million.
"We're going to continue the commercialization of our fertility product and continue to build and launch our pregnancy product in the next few months," Wallace said....
April 17, 2013
The most important thing about a thermometer isn't that it takes your temperature. What's important about a thermometer, according to Kinsa Health founder Inder Singh, is that it's already the go-to device for home diagnosis of illness.
"The thermometer is the single most important device," Singh told MobiHealthNews, "the first device any parent or doctor uses to confirm illness."
January 17, 2013
Digital health apps and services for health issues related to pregnancy, fertility, and conception have been available for years now. Even way back in early 2009 when we conducted our very first health and medical apps report we found that already 250 apps related to women's health issues were available for iPhone users. Our most recent count puts the figure closer to 1,000. Beyond apps there is...